07/07/2025
12:42 PM | Capital International Investors (Filed by)
NovoCure (Subject)
| Form SCHEDULE 13G/A | |
06/06/2025
3:26 PM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
3:13 PM | NovoCure (Issuer)
VERNON W ANTHONY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:14 PM | Hung David (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:15 PM | NovoCure (Issuer)
Scannell Timothy J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:16 PM | NovoCure (Issuer)
Ocean Allyson J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:17 PM | HILLEMAN JERYL L (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:19 PM | Madden Martin J. (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:26 PM | NovoCure (Issuer)
Stafford Kristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
3:25 PM | Leonard Frank X (Reporting)
NovoCure (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2025
5:05 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for NVCR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NovoCure and its competitors with MarketBeat's FREE daily newsletter. |
05/05/2025
3:17 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2025
6:01 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2025
6:02 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
7:00 PM | BlackRock, Inc. (Filed by)
NovoCure (Subject)
| Form SCHEDULE 13G/A | |
04/22/2025
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
6:01 AM | NovoCure (Filer)
| Form DEF 14A | |
04/21/2025
6:02 AM | NovoCure (Filer)
| Form DEFA14A | |
04/01/2025
4:00 PM | NovoCure (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SCHEDULE 13G | |
03/06/2025
3:40 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:41 PM | Leonard Frank X (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:41 PM | NovoCure (Issuer)
Weinberg Uri (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:41 PM | NovoCure (Issuer)
Puri Michal Nath (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:42 PM | Ben Arye Barak (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:42 PM | Leupin Nicolas (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
3:48 PM | Brackmann Christoph (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
8:27 PM | NovoCure (Issuer)
Weinberg Uri (Reporting)
| Form 4/A | |
03/03/2025
8:26 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 4/A | |
03/03/2025
8:26 PM | Leupin Nicolas (Reporting)
NovoCure (Issuer)
| Form 4/A | |
03/03/2025
8:26 PM | NovoCure (Issuer)
Puri Michal Nath (Reporting)
| Form 4/A | |
03/03/2025
8:26 PM | Leonard Frank X (Reporting)
NovoCure (Issuer)
| Form 4/A | |
03/03/2025
8:26 PM | Cordova Ashley (Reporting)
NovoCure (Issuer)
| Form 4/A | |
03/03/2025
4:31 PM | NovoCure (Subject)
Paravasthu Mukund (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
4:34 PM | Leonard Frank X (Reporting)
NovoCure (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:01 PM | NovoCure (Subject)
Weinberg Uri (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
3:43 PM | Cordova Ashley (Reporting)
NovoCure (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
3:50 PM | NovoCure (Subject)
Paravasthu Mukund (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
3:36 PM | GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
6:01 AM | NovoCure (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:02 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:05 AM | NovoCure (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
I warned you about Nvidia… now look what’s happening (Ad) Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open.
That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits. Watch how Tim Sykes trades AI headlines for real gains |
01/15/2025
3:23 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:28 PM | NovoCure (Subject)
Paravasthu Mukund (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:27 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
6:02 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
6:00 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024
3:05 PM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
5:21 PM | NovoCure (Issuer)
Paravasthu Mukund (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
3:16 PM | NovoCure (Issuer)
Puri Michal Nath (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:17 PM | Leonard Frank X (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:19 PM | Cordova Ashley (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:19 PM | Danziger Asaf (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
7:19 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:20 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:21 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:22 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:24 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:25 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:16 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:17 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
7:18 AM | NovoCure (Filer)
| Form S-8 POS | |
07/25/2024
6:01 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2024
6:05 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
